Johnson & Johnson
$250.57-2.47Capitalisation boursière
$632.3B
Rang mondial
#21
Sommet historique
$643.3B
2026-07-07
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 94% of the 367 companies we track (globally).
- Equivalent to 2.1% of United States's GDP (2025 data).
- Just above: #20 ExxonMobil ($663.9B)
- Just below: #22 Visa ($611.5B)
- Best year: 1995 (+59%). Worst year: 2023 (-9%).
Johnson & Johnson Financial Breakdown (FY 2025)
Source: Yahoo Finance — JNJ annual filings (2025) →$94.2B revenue · $25.6B operating income · $26.8B net income
- ●Operating margin: 27.2% on $94.2B in revenue.
- ●R&D is 15.6% of revenue ($14.7B).
- ●Net income margin: 28.5% — $26.8B in profit.
- ●Free cash flow: $19.3B (20.5% of revenue).
Cost / Operating Expenses
Total operating expenses $68.6B
Total
$68.6B
Capital Expenditures
$5.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$19.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
28.9
EPS
$8.60
Net margin
21.8%
ROE
26.3%
Dividend yield
2.09%
Debt / Equity
0.68
À propos de Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Historique de la capitalisation boursière de Johnson & Johnson (2026–2026)
Johnson & Johnson vs Sector Peers by Market Cap
Comparer Johnson & Johnson
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $632.3B | #21(↓1) | +28.3% |
| 2025 | $492.7B | #20(↑5) | +47.5% |
| 2024 | $334.1B | #25(↓5) | -4.8% |
| 2023 | $351.0B | #20(↓10) | -8.6% |
| 2022 | $383.9B | #10(↑5) | +6.0% |
| 2021 | $362.3B | #15(↓1) | +11.4% |
| 2020 | $325.1B | #14(↓1) | +10.8% |
| 2019 | $293.3B | #13(↓4) | +16.2% |
| 2018 | $252.4B | #9 | -5.1% |
| 2017 | $266.0B | #9(↓1) | +24.4% |
| 2016 | $213.8B | #8(↓1) | +15.3% |
| 2015 | $185.4B | #7(↓1) | +1.1% |
| 2014 | $183.3B | #6(↑2) | +17.3% |
| 2013 | $156.2B | #8(↑1) | +34.6% |
| 2012 | $116.0B | #9(↓2) | +10.8% |
| 2011 | $104.7B | #7(↑3) | +9.9% |
| 2010 | $95.3B | #10(↓6) | -0.6% |
| 2009 | $95.8B | #4(↑3) | +11.3% |
| 2008 | $86.1B | #7(↑5) | -7.7% |
| 2007 | $93.3B | #12(↓4) | +3.6% |
| 2006 | $90.1B | #8(↑1) | +12.4% |
| 2005 | $80.1B | #9 | -3.4% |
| 2004 | $82.9B | #9(↑2) | +25.2% |
| 2003 | $66.2B | #11(↓3) | -2.1% |
| 2002 | $67.6B | #8(↑3) | -7.9% |
| 2001 | $73.4B | #11(↑4) | +14.0% |
| 2000 | $64.4B | #15(↑3) | +14.2% |
| 1999 | $56.4B | #18(↓2) | +12.5% |
| 1998 | $50.1B | #16(↑1) | +29.0% |
| 1997 | $38.9B | #17(↓1) | +34.3% |
| 1996 | $28.9B | #16(↓4) | +18.1% |
| 1995 | $24.5B | #12(↑3) | +59.1% |
| 1994 | $15.4B | #15 |
Autres entreprises du secteur Santé
FAQ
What is Johnson & Johnson's market cap?
Johnson & Johnson (JNJ) has a market capitalization of $632.3B, making it the #21 largest company in the world by market cap.
What was Johnson & Johnson's highest market cap?
Johnson & Johnson's all-time high market cap was $643.3B, reached in 2026-07-07. Its highest rank was #21 in 2026.
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Johnson & Johnson's market cap changed over time?
Johnson & Johnson has been tracked since 2026. Its market cap has grown by 0% from $632.3B in 2026 to $632.3B today.